FS Bancorp Insider: Nesbitt Granted Shares and Options, Reports Sale
Rhea-AI Filing Summary
Robert A. Nesbitt, Chief Credit Operations, EVP and a director of FS Bancorp, Inc. (FSBW), reported Section 16 transactions dated 08/15/2025. He was awarded 1,800 shares of restricted common stock under the 2018 Equity Incentive Plan, which vest 25% per year beginning August 15, 2026. He was also granted 3,600 stock options with a $40.14 exercise price, exercisable beginning August 15, 2026 and expiring August 15, 2035. The report shows a sale/disposition of 185 common shares at $40.14. Following the transactions, Mr. Nesbitt beneficially owned reported totals of 4,532 common shares direct, 1,313 indirect via an ESOP, and 9,200 underlying shares from options.
Positive
- Time-based vesting for both restricted stock and options (25% per year) supports executive retention.
- Options have a long term (expires 08/15/2035), giving management multi-year alignment with shareholder value creation.
- Transactions are fully disclosed on Form 4 with explanations and signature, indicating compliance.
Negative
- Insider disposition of 185 shares at $40.14 was reported, reducing direct holdings.
- Options and awards increase potential share overhang when exercised or vested (3,600 options granted).
Insights
TL;DR: Routine equity compensation and an insider sale; grants include time-based vesting and multi-year option term.
The filing documents standard executive compensation activity: a restricted stock award and stock option grant under the companys 2018 Equity Incentive Plan, both vesting 25% annually beginning August 15, 2026. The option exercise price is $40.14 and options expire in 2035, providing long-dated upside potential if the share price rises. The small disposition of 185 shares at $40.14 is recorded the same day. Overall, these are typical retention-oriented awards rather than extraordinary capital actions.
TL;DR: Governance-wise this is a standard, disclosed insider award with clear vesting schedule and Form 4 compliance.
The disclosure clearly states the nature and vesting of equity compensation and reports the required sale. Vesting schedules align with multi-year retention practices. The filing appears complete with signature and explanations for the awards. No governance red flags or undisclosed arrangements are evident from the form itself.
FAQ
What did Robert A. Nesbitt report on Form 4 for FSBW?
When do the restricted shares and options vest for FSBW insider filings?
What is the exercise price and expiration of the options reported on Form 4 (FSBW)?
How many FSBW shares does Nesbitt beneficially own after the transactions?
Was the Form 4 properly signed and dated?
Are the grants described part of a specific equity plan for FSBW?